agilon health, inc. (AGL) Guidance & Earnings Results
On 2026-08-05 agilon health, inc. raised guidance: "FY2026 revenue raised to $5,775M-$5,860M; medical margin to $465M-$505M; Adj EBITDA to…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AGLagilon health, inc.Follow AGL — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Raised | FY2026 revenue raised to $5,775M-$5,860M; medical margin to $465M-$505M; Adj EBITDA to $75M-$95M · full year |
| 6 May 26 | Raised | Full-year 2026 guidance raised for total revenues, medical margin, and Adjusted EBITDA. · full year |
agilon health, inc. — questions
- What guidance did agilon health, inc. give?
- On 2026-08-05: "FY2026 revenue raised to $5,775M-$5,860M; medical margin to $465M-$505M; Adj EBITDA to $75M-$95M"
- When does agilon health, inc. report earnings?
- agilon health, inc.'s next earnings report is expected on 2026-11-04.
Every figure on this page comes from agilon health, inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.